Difference between revisions of "Urothelium"

From Libre Pathology
Jump to navigation Jump to search
m (PBoD)
m (GUP, WMSP)
Line 72: Line 72:
*Invasive UCC.
*Invasive UCC.


Comparison urothelial changes - flat epithelium - benign/premalignant/cancerous:<ref>GUP PP.155-163</ref>
Comparison urothelial changes - flat epithelium - benign/premalignant/cancerous:<ref>{{Ref GUP|155-163}}</ref>
{| class="wikitable"
{| class="wikitable"
| ||'''Normal'''||'''Reactive atypia'''||'''Flat urothelial hyperplasia'''||'''Urothelial dysplasia'''||'''UCC in situ'''||'''Invasive UCC'''
| ||'''Normal'''||'''Reactive atypia'''||'''Flat urothelial hyperplasia'''||'''Urothelial dysplasia'''||'''UCC in situ'''||'''Invasive UCC'''
Line 98: Line 98:
===Microscopic===
===Microscopic===
*Nuclear changes (key feature).
*Nuclear changes (key feature).
**Enlargement of nuclei (often 4-5x the size of stromal lymphocytes) -- diagnostic.<ref>GUP P.161.</ref>
**Enlargement of nuclei (often 4-5x the size of stromal lymphocytes) -- diagnostic.<ref name=Ref_GUP161>{{Ref GUP|161}}</ref>
***Normal urothelium approx. 2x the size of stromal lymphocytes.
***Normal urothelium approx. 2x the size of stromal lymphocytes.
**Nuclear pleomorphism - marked variation in size of nuclei.
**Nuclear pleomorphism - marked variation in size of nuclei.
Line 125: Line 125:


==UCC (papillary lesions)==
==UCC (papillary lesions)==
Papillary urothelial lesions are grouped into one of five categories (listed from bad to good prognosis):<ref name=WMSP_310>WMSP P.310</ref>
Papillary urothelial lesions are grouped into one of five categories (listed from bad to good prognosis):<ref name=Ref_WMSP310>{{Ref WMSP|310}}</ref>
*High grade papillary.
*High grade papillary.
*Low grade papillary.
*Low grade papillary.
Line 139: Line 139:


===High grade papillary UCC===
===High grade papillary UCC===
Micro.<ref name=WMSP_310/>
Micro.<ref name=Ref_WMSP310>{{Ref WMSP|310}}</ref>
*"High grade nuclear features":
*"High grade nuclear features":
**Nuclear pleomorphism - often 4-5x the size of stromal lymphocytes.<ref>GUP P.161.</ref>
**Nuclear pleomorphism - often 4-5x the size of stromal lymphocytes.<ref name=Ref_GUP161>{{Ref GUP|161}}</ref>
*Architectural complexity.
*Architectural complexity.
**Fused papillary common.
**Fused papillary common.
Line 148: Line 148:


===Low grade papillary UCC===
===Low grade papillary UCC===
Micro.<ref name=WMSP_310/>
Micro.<ref name=Ref_WMSP310>{{Ref WMSP|310}}</ref>
*Fused papillae.
*Fused papillae.
*Papillae branch.
*Papillae branch.
Line 154: Line 154:


===PUNLUMP===
===PUNLUMP===
Micro.<ref name=WMSP_310/>
Micro.<ref name=Ref_WMSP310>{{Ref WMSP|310}}</ref>
*Rare fused papillae.
*Rare fused papillae.
*Infrequent mitoses.
*Infrequent mitoses.
*Nuclei larger than papilloma - but monotonous.<ref>GUP P.170.</ref>
*Nuclei larger than papilloma - but monotonous.<ref name=Ref_GUP170>{{Ref GUP|170}}</ref>


===Papilloma===
===Papilloma===
Micro.<ref name=WMSP_310/>
Micro.<ref name=Ref_WMSP310>{{Ref WMSP|310}}</ref>
*Papillary fronds.
*Papillary fronds.
*Minimal branching or fusion.
*Minimal branching or fusion.
*Cytological features of normal urothelium.
*Cytological features of normal urothelium.
**Normal urothelium approx. 2x the size of stromal lymphocytes.<ref>GUP P.161.</ref>
**Normal urothelium approx. 2x the size of stromal lymphocytes.<ref name=Ref_GUP161>{{Ref GUP|161}}</ref>
*No mitoses.
*No mitoses.


===Inverted papilloma===
===Inverted papilloma===
*Like papillomas... but grow downward.<ref name=WMSP_310/>
*Like papillomas... but grow downward.<ref name=Ref_WMSP310>{{Ref WMSP|310}}</ref>


===Tabular comparison of papillary lesions===
===Tabular comparison of papillary lesions===


Urothelial cells in papillae - benign/premalignant/cancerous:<ref>GUP PP.166-175 and WMSP P.310</ref>
Urothelial cells in papillae - benign/premalignant/cancerous:<ref>{{Ref GUP|166-175}}</ref><ref name=Ref_WMSP310>{{Ref WMSP|310}}</ref>
{| class="wikitable"
{| class="wikitable"
| ||'''Papilloma''' ||'''PUNLMP''' ||'''low grade PUCC''' ||'''high grade PUCC'''
| ||'''Papilloma''' ||'''PUNLMP''' ||'''low grade PUCC''' ||'''high grade PUCC'''

Revision as of 03:44, 20 June 2010

The urothelium lines the upper portion of the genitourinary tract... and a bit of the lower part.

Extent of urothelium

Urethra in males

  • Pre-prostatic urethra - transistional epithelium.
  • Prostatic urethra - transistional epithelium.
  • Membranous urethra (from apex of prostate to bulb of penis (bulb of the corpus spongiosusm)) - pseudostrat. columnar epithelium.
  • Spony urethra - pseudostratified columnar epi. (proximal) & strat. squamous (distal).

Normal histology

  • Prominent nucleoli (???).
  • Maturation (cuboidal at base - squamoid at surface).
    • Surface cells called 'umbrella cells' (umbrella cells CK20+).
  • Urothelium should be 4-5 cell layers thick.
  • Should NOT have papillary architecture -- if it does it is likely cancer!
    • If it is 'papillary' -- it must have fibrovascular cores.

Where to start

July 1st PGY-2:

  1. Urothelial carcinoma - essentially defined by increased nuclear size +/- irreg. nuclear contour.
    • Nucleoli are common in urothelium.
      • This can be confusing... prostate carcinoma has nucleoli.
    • Mitosis - these are key if the nuclear enlargement is not present.[1]
    • Cell-depleted urothelium, where the cells have shed-off--but a few remain, should raise suspicions to cancer.
      • Thickness of the urothelium, otherwise, isn't very useful for diagnosing cancer.
  2. Round structures should make you think of papillae and prompt looking for fibrovascular cores.
  3. Fibrovascular cores = papillae... may be cancer!

Note about terminology

  • The bladder is rather unique in that "carcinoma" is a label used for things that are non-invasive.
    • It has been suggested that many things that are called papillary urothelial carcinoma, would be better described as papillary intraurothelial neoplasia.[2]
    • If the terminology in the urinary bladder were applied to the colon, we'd call all adenomas, i.e. pre-malignant lesions, carcinomas.

Approach

  1. Papillary structure - with fibrovascular cores?
    • Nuclear pleomorphism?
      • Yes - high grade (4-5x lymphocyte) --> Dx: high grade papillary urothelial carcinoma
      • No - low grade or normal (2-3x lymphocyte) --> DDx: low grade papillary urothelial carcinoma, PUNLMP, papilloma
  2. Flat lesions?
    • Nuclear pleomorphism?
  3. Maturation to surface?
    • No --> Dx: sectioning artefact vs. flat UCC.
    • Yes --> likely benign.
  4. Normal thickness?
    • normal is 4-5 cell layers.
  5. Nests of glandular cells
    • consider cystitis cystica, cystitis glandularis, Brunn's nest, inverted papilloma.
  6. Inflammation?
    • Michaelis-Gutman bodies?

Pitfalls:

  • Urothelial carcinoma of the bladder may be confused with a paraganglioma of the bladder.
    • Way to differentiate: paraganglioma = stippled chromatin, UCC = single nucleoli.

Risk factors for UCC

Risk factors for UCC:

  • Smoking.
  • Toxins.
  • Drugs, e.g. cyclophosphamide.
  • Marijuana.[3]
  • Chinese Herbs.[4]

Premalignant/Hyperplasic/Reactive changes

Several different benign/premalignant diagnoses can be made:

  • Reactive atypia.
  • Flat urothelial hyperplasia.
  • Urothelial dysplasia.

Cancer

  • Urothelial carcinoma in situ.
  • Invasive UCC.

Comparison urothelial changes - flat epithelium - benign/premalignant/cancerous:[5]

Normal Reactive atypia Flat urothelial hyperplasia Urothelial dysplasia UCC in situ Invasive UCC
Nuclear enlargement
(X stromal lymphocyte)		 none (2x) moderate, prominent (3x) none (2x) moderate (3x) signif. (4-5x) signif. (4-5X)
Nucleoli small prominent small small, some multiple +/-large +/-large
size var., shape none, round none, round none, round mod. variation, some irregularity marked, irregular marked, irregular
Polarity matures to surface as normal as normal lost lost lost
Mitoses none/minimal some, none atypical as normal rare, none atypical common, atypical common, atypical
Thickness 4-5 cells as normal increased as normal thin, thick or norm. thin, thick or norm.
Inflammation none severe, acute or chronic usu. none usu. none +/- +/-
Other - - - - - stromal invasion

The bold entry is considered the key feature.

Urothelial carcinoma in situ

Microscopic

  • Nuclear changes (key feature).
    • Enlargement of nuclei (often 4-5x the size of stromal lymphocytes) -- diagnostic.[6]
      • Normal urothelium approx. 2x the size of stromal lymphocytes.
    • Nuclear pleomorphism - marked variation in size of nuclei.
  • Disordered arrangement/crowding of cells.
    • In normal urothelium the cell line-up on the basement membrane.
  • Umbrella cells often absent.
  • Mitoses present.
  • +/-Enlarged nucleoli.

Urothelial cell carcinoma UCC (flat)

  • Nuclear pleomorphism.
    • Most important feature.
    • Compare nuclei to one another.
  • Increased N/C ratio.
  • Lack of maturation to surface (important).
  • Cells become dyscohesive.
    • Mostly useless in my experience.

IHC

  • CK7+ CK20+.

UCC vs. Prostate

  • UCC: p63+, PSA-, PSAP-, CK7+, CK20+.
  • Prostate: p63-, PSA+, PSAP+, CK7-, CK20-.

UCC (papillary lesions)

Papillary urothelial lesions are grouped into one of five categories (listed from bad to good prognosis):[7]

  • High grade papillary.
  • Low grade papillary.
  • Papillary urothelial neoplasm of low malignant potential (PUNLMP).
    • PUNLMP is pronouced "pun-lump".
  • Inverted papilloma.
  • Urothelial papilloma.

Key characteristics:

  1. Nuclear - size/pleomorphism.
  2. Papillae branching.
  3. Papillae fusion.

High grade papillary UCC

Micro.[7]

  • "High grade nuclear features":
    • Nuclear pleomorphism - often 4-5x the size of stromal lymphocytes.[6]
  • Architectural complexity.
    • Fused papillary common.
    • Papillae branch.
  • Mitoses common.

Low grade papillary UCC

Micro.[7]

  • Fused papillae.
  • Papillae branch.
  • Larger nuclei than PUNLMPs.

PUNLUMP

Micro.[7]

  • Rare fused papillae.
  • Infrequent mitoses.
  • Nuclei larger than papilloma - but monotonous.[8]

Papilloma

Micro.[7]

  • Papillary fronds.
  • Minimal branching or fusion.
  • Cytological features of normal urothelium.
    • Normal urothelium approx. 2x the size of stromal lymphocytes.[6]
  • No mitoses.

Inverted papilloma

  • Like papillomas... but grow downward.[7]

Tabular comparison of papillary lesions

Urothelial cells in papillae - benign/premalignant/cancerous:[9][7]

Papilloma PUNLMP low grade PUCC high grade PUCC
papillae features fat papillae,
thick FV core		 slender FV core slender FV core,
thick epithelium		 mixed population
papillae branching rare uncommon frequent common
papillae fusion none rare some common
nuclear size normal (2x lymphocyte) enlarged - uniform enlarged with variation 4-5x lymphocyte,
marked pleomorphism
mitoses very rare basal rare basal only infreq., usually basal common, everywhere
DDx PUNLMP, low gr. PUCC papilloma, low gr. PUNLMP, high gr. low gr., invasive UCC
IHC p53-, CK20+ umbrella cells CK20+ umbrella -/+ p53, CK20+ umbrella diffuse CK20+, p53+ in 50%
Other cytologically normal low cellular density (@ low power) vs. low gr.[10] +/- small nucleoli nucleoli prominent
Key feature normal cells,
fat papillae		 uniformly enlarged cell pop.,
slender papillae		 nuc. pleomorphism,
thick epithelium		 marked nuclear pleomorphism

Notes:

  • FV core = fibrovascular core.
  • PUCC = papillary urothelial carcinoma.

Benign

Brunn nests:[11]

  • Benign inbudding nests of urothelium.
    • Should lead to consideration of "inverted papilloma".

Cystitis cystica:[11]

  • Brunn nests with urothelium.

cystitis glandularis:[11]

  • Brunn nests with cuboidal and columnar epithelium.

Invasive UCC

Staging:

  • T1 - lamina propria.
    • Several subdivisions of T1 exist:[12]
      • T1a - superficial or in muscularis mucosae.
      • T1b - beyond muscularis mucosae - into submucosa.
  • T2 - muscularis propria.

Invasion vs. in situ

Useful features - present in invasion:[13]

  • Thin-walled vessels.
  • Stromal reaction (hypercellularity).
  • Retraction artefact around the tumour cell nests.

Renal cell carcinoma

Main article: Renal cell carcinoma

Clinically, it may not be possible to differentiate renal pelvis UCC and RCC.

See also

References

  1. ↑ JS. 9 June 2010.
  2. ↑ Van der Kwast, TH.; Zlotta, AR.; Fleshner, N.; Jewett, M.; Lopez-Beltran, A.; Montironi, R. (Dec 2008). "Thirty-five years of noninvasive bladder carcinoma: a plea for the use of papillary intraurothelial neoplasia as new terminology.". Anal Quant Cytol Histol 30 (6): 309-15. PMID 19160695.
  3. ↑ PMID 16413342.
  4. ↑ URL: http://content.nejm.org/cgi/content/full/343/17/1268. Accessed on: 27 May 2010.
  5. ↑ Zhou, Ming; Magi-Galluzzi, Cristina (2006). Genitourinary Pathology: A Volume in Foundations in Diagnostic Pathology Series (1st ed.). Churchill Livingstone. pp. 155-163. ISBN 978-0443066771.
  6. ↑ 6.0 6.1 6.2 Zhou, Ming; Magi-Galluzzi, Cristina (2006). Genitourinary Pathology: A Volume in Foundations in Diagnostic Pathology Series (1st ed.). Churchill Livingstone. pp. 161. ISBN 978-0443066771.
  7. ↑ 7.0 7.1 7.2 7.3 7.4 7.5 7.6 Humphrey, Peter A; Dehner, Louis P; Pfeifer, John D (2008). The Washington Manual of Surgical Pathology (1st ed.). Lippincott Williams & Wilkins. pp. 310. ISBN 978-0781765275.
  8. ↑ Zhou, Ming; Magi-Galluzzi, Cristina (2006). Genitourinary Pathology: A Volume in Foundations in Diagnostic Pathology Series (1st ed.). Churchill Livingstone. pp. 170. ISBN 978-0443066771.
  9. ↑ Zhou, Ming; Magi-Galluzzi, Cristina (2006). Genitourinary Pathology: A Volume in Foundations in Diagnostic Pathology Series (1st ed.). Churchill Livingstone. pp. 166-175. ISBN 978-0443066771.
  10. ↑ GAG. 26 February 2009.
  11. ↑ 11.0 11.1 11.2 Cotran, Ramzi S.; Kumar, Vinay; Fausto, Nelson; Nelso Fausto; Robbins, Stanley L.; Abbas, Abul K. (2005). Robbins and Cotran pathologic basis of disease (7th ed.). St. Louis, Mo: Elsevier Saunders. pp. 1028. ISBN 0-7216-0187-1.
  12. ↑ Sternberg, H4P 4th Ed., P.2048-9.
  13. ↑ Sternberg, H4P, P.2047.
Retrieved from "https://librepathology.org/w/index.php?title=Urothelium&oldid=798"